I'm John Bachelor, and I'm speaking to Dr. Henry Miller, a physician.

We turn from the FDA to another three-letter institution, MIT.

And Henry, I work with AI all the time.

I have Claudette in full conversation about history,

and Claudette also does a wonderful job of formatting my documents.

At the same time, I'm reading

in Science Magazine and Nature magazine that AI has surprising value for scientific endeavor and for

thoroughness. I learn now that AI is being used by researchers at MIT to search out a problem I've always heard about, which is

that the abuse of antibiotics, that is, you don't take your full course of antibiotics, you're supposed

to take it for 10 days and you take it for three, you feel better, and you just lose the pills.

That that is increasingly a threat if you're in a hospital,

for example, with afflictions that can't be solved by antibiotics. Have I said that correctly,

doctor? Yes, John. You have. But as you intamated, antibiotic resistance is a huge and

increasing public health problem.

We haven't had a new class of antibiotics developed for half a century.

Darwinian evolution being what it is, survival of the fittest, bacteria that have mutations that enable them to resist the

available antibiotics proliferate and become useless. And we're seeing that more and more.

In fact, many of your listeners may have had the experience of a skin infection with

Staphylococcus or some sort of pneumonia or other

respiratory infection where antibiotics were first tried, didn't succeed, and their physicians had to go

to a second line antibiotic, which might not be as effective normally

or which has greater side effects. So we desperately need new antibiotics and new approaches.

...